First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma

This is the first human study of a new drug called EMB-07 for people with hard-to-treat advanced solid tumors or relapsed/refractory lymphoma. Treatment Group A includes specific solid tumors, and Treatment Group B includes lymphoma. **You may be eligible if...** - You are 18 years or older - Treatment Group A: You have advanced unresectable or metastatic cancer of the breast (triple-negative), lung (adenocarcinoma), ovary, pancreas, colon/rectum, stomach, prostate, bladder, or uterus - Treatment Group B: You have a relapsed or refractory lymphoma confirmed by biopsy - You are willing and able to comply with all study procedures **You may NOT be eligible if...** - Your cancer type is not listed above - You have inadequate organ function, serious heart conditions, or active infections - You are pregnant or breastfeeding (check with your doctor for full exclusion criteria) Talk to your doctor to see if this trial is right for you.